Sweroside alleviates pressure overload-induced heart failure through targeting CaMKⅡδ to inhibit ROS-mediated NF-κB/NLRP3 in cardiomyocytes.
- DOI
- 10.1016/j.redox.2024.103223
- Published
- 2024 Aug
- Container
- Redox biology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.redox.2024.103223,
title = {Sweroside alleviates pressure overload-induced heart failure through targeting CaMKⅡδ to inhibit ROS-mediated NF-κB/NLRP3 in cardiomyocytes.},
author = {Wang D and Yu X and Gao K and Li F and Li X and Pu H and Zhang P and Guo S and Wang W},
year = {2024},
journal = {Redox biology},
doi = {10.1016/j.redox.2024.103223},
url = {https://doi.org/10.1016/j.redox.2024.103223}
}RIS
TY - JOUR TI - Sweroside alleviates pressure overload-induced heart failure through targeting CaMKⅡδ to inhibit ROS-mediated NF-κB/NLRP3 in cardiomyocytes. AU - Wang D AU - Yu X AU - Gao K AU - Li F AU - Li X AU - Pu H AU - Zhang P AU - Guo S AU - Wang W PY - 2024 JO - Redox biology DO - 10.1016/j.redox.2024.103223 UR - https://doi.org/10.1016/j.redox.2024.103223 ER -
APA
D, W., X, Y., K, G., F, L., X, L., H, P., P, Z., S, G., & W, W. (2024). Sweroside alleviates pressure overload-induced heart failure through targeting CaMKⅡδ to inhibit ROS-mediated NF-κB/NLRP3 in cardiomyocytes.. Redox biology. https://doi.org/10.1016/j.redox.2024.103223
Source records
- pubmed · retrieved 2026-09-25T22:17:09.185Z